CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CF CF Industries Holdings Inc

Market Closed 02-14 16:00:00 EST

82.48

+1.52

+1.88%

盘后82.48

+0.000.00%

18:42 EST

High83.69	Low81.48	Vol2.19M
Open81.79	D1 Closing80.96	Amplitude2.73%
Mkt Cap14.35B	Tradable Cap14.23B	Total Shares174.02M
T/O181.48M	T/O Rate1.27%	Tradable Shares172.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"CF","market":"US","secType":"STK","nameCN":"CF Industries Holdings Inc","latestPrice":82.48,"timestamp":1739566800000,"preClose":80.96,"halted":0,"volume":2192078,"hourTrading":{"tag":"盘后","latestPrice":82.48,"preClose":82.48,"latestTime":"18:42 EST","volume":43713,"amount":3605446.8,"timestamp":1739576540339},"delay":0,"floatShares":172473048,"shares":174019929,"eps":6.292587,"marketStatus":"Market Closed","change":1.52,"latestTime":"02-14 16:00:00 EST","open":81.79,"high":83.69,"low":81.48,"amount":181482795.2434,"amplitude":0.027297,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.292587,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1739869200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1123732800000,"exchange":"NYSE","adjPreClose":80.96,"dividendRate":0.023036,"preHourTrading":{"tag":"盘前","latestPrice":82.13,"preClose":80.96,"latestTime":"09:29 EST","volume":114,"amount":9362.51961,"timestamp":1739543399087},"postHourTrading":{"tag":"盘后","latestPrice":82.48,"preClose":82.48,"latestTime":"18:42 EST","volume":43713,"amount":3605446.8,"timestamp":1739576540339},"volumeRatio":0.6476194049293326,"impliedVol":0.4281,"impliedVolPercentile":0.9801},"requestUrl":"/m/hq/s/CF","defaultTab":"news","newsList":[{"id":"2511871672","title":"2 Healthcare Stocks That Tumbled in 2024...but Could See an Impressive Comeback in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2511871672","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511871672?lang=en_us&edition=fundamental","pubTime":"2025-02-15 20:45","pubTimestamp":1739623500,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals and AstraZeneca faced some issues that sank their stock prices last year.For both companies, these headwinds do little to radically alter their solid long-term prospects.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/15/2-healthcare-stocks-that-tumbled-in-2024-but-could/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1559883803.SGD","IE00B894F039.SGD","BK4533","LU0823416689.USD","LU1093756168.USD","LU2362541513.USD","IE00BJT1NW94.SGD","IE00B19Z9Z06.USD","LU0289739699.SGD","VRTX","LU1815336091.USD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU0417517546.SGD","LU2362540622.SGD","LU1585245621.USD","LU2237438978.USD","BK4139","HCSG","IE00B19Z3B42.SGD","IE0009355771.USD","LU2362541273.HKD","IE0002141913.USD","BK4093","BK4588","CF","BK4532","LU0109394709.USD","BK4023","IE0002270589.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU0234570918.USD","LU2462157665.USD","LU0757428866.USD","VERX","LU0061475181.USD","BK4137","LU2236285917.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4567","IE00B2B36J28.USD","LU0320765992.SGD","LU1093756325.SGD","IE00BZ9MQY76.HKD","LU0058720904.USD","LU0256863811.USD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2511433136","title":"CF Industries Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2511433136","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511433136?lang=en_us&edition=fundamental","pubTime":"2025-02-15 06:15","pubTimestamp":1739571300,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  advanced 1.88% to $82.48 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.01% to 6,114.63 and Dow Jones Industrial Average  falling 0.37% to 44,546.08.This was the stock's second consecutive day of gains.CF Industries Holdings Inc. closed 16.05% below its 52-week high of $98.25, which the company reached on January 16th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Mosaic Co.  rose 0.30% to $26.51 and Westlake Corp.  rose 2.39% to $115.27.Trading volume  eclipsed its 50-day average volume of 2.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 14, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2511455266","title":"Is There An Opportunity With CF Industries Holdings, Inc.'s (NYSE:CF) 41% Undervaluation?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511455266","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511455266?lang=en_us&edition=fundamental","pubTime":"2025-02-15 02:32","pubTimestamp":1739557928,"startTime":"0","endTime":"0","summary":"Key Insights Using the 2 Stage Free Cash Flow to Equity, CF Industries Holdings fair value estimate is US$139 CF...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice1-main-header/1585186651478"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-cf/cf-industries-holdings/news/is-there-an-opportunity-with-cf-industries-holdings-incs-nys-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4093","DCF","BK4211","BK4100","FCF","TV","BK4588","CF","BK4585","NYSE"],"gpt_icon":0},{"id":"2511909046","title":"DIARY-U.S. earnings week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2511909046","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511909046?lang=en_us&edition=fundamental","pubTime":"2025-02-15 01:00","pubTimestamp":1739552400,"startTime":"0","endTime":"0","summary":"DIARY-U.S. earnings week aheadFeb 14 (Reuters) - Diary of U.S. (.SPX) corporate earnings for the week ahead.** Please Note - All times given are in U.S. EDT unless otherwise stated **  U.S. EARNINGS S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nL4N3P50Z1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLDR","GPC","CSGP","LKQ","CDNS","CE","CPRT","EXPD","MDT","TRMB","BAX","PWR","TPL","DVN","POOL","EQT","ANSS","LNT","ANET","GRMN","WMT","ADI","IFF","ETR","TRGP","PODD","ALLE","OXY","CF","NDSN","AKAM","EPAM","BKNG","VMC","AWK","NEM","CRL","PGR","CNP","ED","HAS","LYV"],"gpt_icon":1},{"id":"2511466706","title":"European Commission Approves CSL and Arcturus Therapeutics’ KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2511466706","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511466706?lang=en_us&edition=fundamental","pubTime":"2025-02-14 21:00","pubTimestamp":1739538000,"startTime":"0","endTime":"0","summary":"- KOSTAIVE represents a significant advancement in vaccine technology, demonstrating superior immunogenicity and antibody persistence for up to 12 months post-vaccination compared to conventional mRNA COVID-19 vaccines in clinical trials. WALTHAM, Mass. & SAN DIEGO, February 14, 2025----Global biotechnology leader CSL  and sa-mRNA pioneer Arcturus Therapeutics  today announced that the European Commission has granted marketing authorization for KOSTAIVE , a self-amplifying mRNA COVID-19 vaccine, for individuals 18 years and older. KOSTAIVE is the first sa-mRNA COVID-19 vaccine to receive approval from the European Commission . KOSTAIVE is currently marketed in Japan against COVID-19.\"The European Commission's approval marks a significant milestone in our ongoing development program for KOSTAIVE,\" said Jonathan Edelman, MD, Senior Vice President of the Vaccines Innovation Unit, CSL. \"We are actively working to optimize KOSTAIVE's formulation to better meet the needs of healthcare profes","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-approves-csl-arcturus-130000357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RNA","SGXZ23171101.USD","BK7067","BK4588","BK4535","LU1169590202.USD","BK4585","BK7501","BNTX","BK4086","BK4093","BK7508","BK4139","CHMP","BK4201","LU1169589451.USD","BK4568","BK7511","EC","BK4551","LU0728928796.USD","CF","CSL.AU","LENZ","CSL","BK4087","BK4505","BK4548","SG9999004303.SGD"],"gpt_icon":0},{"id":"2511066573","title":"CF Bankshares Full Year 2024 Earnings: EPS: US$2.13 (vs US$2.64 in FY 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511066573","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511066573?lang=en_us&edition=fundamental","pubTime":"2025-02-14 18:30","pubTimestamp":1739529046,"startTime":"0","endTime":"0","summary":"Profit margin: 30% . The decrease in margin was driven by lower revenue.NasdaqCM:CFBK Earnings and Revenue History February 14th 2025. All figures shown in the chart above are for the trailing 12 month  period. CF Bankshares shares are up 2.0% from a week ago.We don't want to rain on the parade too much, but we did also find 2 warning signs for CF Bankshares (1 is potentially serious!) that you need to be mindful of.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cf-bankshares-full-2024-earnings-103046608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","CFBK"],"gpt_icon":0},{"id":"2511540665","title":"The Ultimate Healthcare Stock to Buy With $500 Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2511540665","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511540665?lang=en_us&edition=fundamental","pubTime":"2025-02-14 17:47","pubTimestamp":1739526420,"startTime":"0","endTime":"0","summary":"Vertex enjoys a monopoly with its CF therapies and has three new potential blockbusters on the market.The company's powerhouse pipeline and hefty cash stockpile could fuel more growth in the future.Vertex is also reasonably valued factoring in its tremendous growth prospects.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/14/the-ultimate-healthcare-stock-to-buy-with-500-righ/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IE00B19Z3B42.SGD","PEG","BK4139","HCSG","IE00BMG7P587.USD","LU0079474960.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU2362540622.SGD","IE00B894F039.SGD","ULTI","LU2362541273.HKD","LU1093756168.USD","LU0889565916.HKD","IE00B19Z3581.USD","LU0566484027.USD","LU0061475181.USD","IE00BD4GTV84.USD","BK4023","IE00B19Z9P08.USD","IE0002270589.USD","IE00BMG7P926.USD","BK4137","LU2362541513.USD","LU1559883803.SGD","LU0417517546.SGD","LU1069344957.HKD","BK4533","LU0320765992.SGD","IE0009355771.USD","BK4093","IE00BFTCPJ56.SGD","LU1585245621.USD","IE00B19Z9Z06.USD","CF","LU1815336091.USD","VERX","VRTX","LU2324357040.USD","LU2462157665.USD","IE0002141913.USD","LU2236285917.USD","BK4532","LU1035775433.USD","LU0256863811.USD","IE00BMG7P819.SGD"],"gpt_icon":0},{"id":"2511657478","title":"Vertex Pharmaceuticals Gets a Huge FDA Approval Which Could Send the Stock Skyrocketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511657478","media":"Motley Fool","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511657478?lang=en_us&edition=fundamental","pubTime":"2025-02-14 16:35","pubTimestamp":1739522100,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals recently obtained approval for its non-opioid pain medication.The drug could become a blockbuster and a key part of Vertex's portfolio.The stock has been rising in value this year, and there could still be much more of a rally to come.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/14/vertex-pharmaceuticals-gets-a-huge-fda-approval-wh/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU0256863811.USD","VERX","LU2417539215.USD","IE00BJT1NW94.SGD","IE00B894F039.SGD","IE00BFTCPJ56.SGD","LU0417517546.SGD","LU2362541273.HKD","LU0058720904.USD","LU1093756168.USD","LU2462157665.USD","BK4585","LU2237438978.USD","IE0002270589.USD","IE00B19Z9P08.USD","LU0234570918.USD","BK4532","LU0109394709.USD","IE00B2B36J28.USD","LU1035775433.USD","BK4139","LU2324357040.USD","LU1815336091.USD","LU2236285917.USD","IE0002141913.USD","LU0320765992.SGD","LU1430594728.SGD","LU0289739699.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0757428866.USD","LU1093756325.SGD","CF","LU0061475181.USD","LU2362541513.USD","LU0079474960.USD","IE0009355771.USD","LU0566484027.USD","LU1585245621.USD","BK4023","LU2456880835.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","BK4093","BK4588","LU0823416689.USD","LU1069344957.HKD","IE00BJJMRZ35.SGD","VRTX"],"gpt_icon":0},{"id":"2511760835","title":"Will CF (CF) Beat Estimates Again in Its Next Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511760835","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511760835?lang=en_us&edition=fundamental","pubTime":"2025-02-14 01:10","pubTimestamp":1739466607,"startTime":"0","endTime":"0","summary":"Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report?It is worth considering CF Industries , which belongs to the Zacks Fertilizers industry.This fertilizer maker has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 37.70%.With this earnings history in mind, recent estimates have been moving higher for CF. In fact, the Zacks Earnings ESP  for the company is positive, which is a great sign of an earnings beat, especially when you combine this metric with its nice Zacks Rank.CF currently has an Earnings ESP of +1.25%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3  indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on February 1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cf-cf-beat-estimates-again-171007150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF"],"gpt_icon":0},{"id":"2511524084","title":"What Analyst Projections for Key Metrics Reveal About CF (CF) Q4 Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524084","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511524084?lang=en_us&edition=fundamental","pubTime":"2025-02-13 22:15","pubTimestamp":1739456118,"startTime":"0","endTime":"0","summary":"Wall Street analysts forecast that CF Industries  will report quarterly earnings of $1.49 per share in its upcoming release, pointing to no change from the year-ago quarter. It is anticipated that revenues will amount to $1.47 billion, exhibiting a decline of 6.7% compared to the year-ago quarter.Over the last 30 days, there has been a downward revision of 7.7% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.Analysts expect 'Net Sales- UAN ' to come in at","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/analyst-projections-key-metrics-reveal-141518058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF"],"gpt_icon":0},{"id":"2511528196","title":"CF Industries to Post Q4 Earnings: What's in the Cards for the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511528196","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511528196?lang=en_us&edition=fundamental","pubTime":"2025-02-13 20:43","pubTimestamp":1739450580,"startTime":"0","endTime":"0","summary":"CF Industries Holdings, Inc. CF is set to release fourth-quarter 2024 results after the closing bell on Feb. 19.See the Zacks Earnings Calendar to stay ahead of market-making news.CF Industries beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters and missed twice. The company delivered a trailing four-quarter earnings surprise of 10.2%, on average. CF is expected to have benefited from healthy nitrogen fertilizer demand in major markets and lower natural gas costs in the fourth quarter. Lower year-over-year selling prices are likely to have impacted its performance.Shares of CF Industries have gained 4.6% in the past year compared with the Zacks Fertilizers industry’s 4.3% rise.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cf-industries-post-q4-earnings-124300857.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF","HUN","POST"],"gpt_icon":0},{"id":"2511654555","title":"CF Bankshares Reports Steady Growth Amid Market Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2511654555","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511654555?lang=en_us&edition=fundamental","pubTime":"2025-02-13 12:00","pubTimestamp":1739419256,"startTime":"0","endTime":"0","summary":"Cf Bankshares Inc ( ($CFBK) ) has released its Q4 earnings. Here is a breakdown of the information Cf Bankshares Inc presented to its investors. CF...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cf-bankshares-reports-steady-growth-amid-market-volatility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cf-bankshares-reports-steady-growth-amid-market-volatility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","CF","BK4093"],"gpt_icon":0},{"id":"2511153356","title":"CF Industries Holdings Inc. Stock Falls 4.6%, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2511153356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511153356?lang=en_us&edition=fundamental","pubTime":"2025-02-13 05:39","pubTimestamp":1739396340,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CF Industries Holdings Inc. shed 4.6% to $81.18 on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.3% to 6,051.97 and Dow Jones Industrial Average falling 0.5% to 44,368.56.This was the stock's second consecutive day of losses.CF Industries Holdings Inc. closed 17.4% short of its 52-week high of $98.25, which the company reached on January 16th.The stock underperformed when compared to some of its competitors, as Mosaic Co. fell 3.0% to $26.14, Westlake Corp. fell 1.3% to $111.07.Trading volume totaled 5.9 million, compared to the 50-day average of 2.0 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2511302817","title":"CF Industries (CF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511302817","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511302817?lang=en_us&edition=fundamental","pubTime":"2025-02-12 23:00","pubTimestamp":1739372445,"startTime":"0","endTime":"0","summary":"CF Industries  is expected to deliver flat earnings compared to the year-ago quarter on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 19. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.Revenues are expected to be $1.47 billion, down 6.7% from the year-ago quarter.Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our rese","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cf-industries-cf-expected-beat-150045792.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CF"],"gpt_icon":0},{"id":"2510693377","title":"CF Bankshares Q4 EPS $0.68 Up From $0.65 YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2510693377","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510693377?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:02","pubTimestamp":1739368957,"startTime":"0","endTime":"0","summary":"CF Bankshares (NASDAQ:CFBK) reported quarterly earnings of $0.68 per share. This is a 4.62 percent increase over earnings of $0.65 per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43657627/cf-bankshares-q4-eps-0-68-up-from-0-65-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF","CFBK"],"gpt_icon":0},{"id":"2510377746","title":"CF BANKSHARES INC., PARENT OF CFBANK NA, REPORTS RESULTS FOR THE 4th QUARTER AND FULL YEAR 2024.","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377746","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510377746?lang=en_us&edition=fundamental","pubTime":"2025-02-12 22:00","pubTimestamp":1739368800,"startTime":"0","endTime":"0","summary":"COLUMBUS, Ohio, Feb. 12, 2025 /PRNewswire/ -- CF Bankshares Inc.  , the parent of CFBank, National Association , today announced financial results for the fourth quarter and the full year ended December 31, 2024.Net income was $4.4 million  for the fourth quarter and $13.4 million for the year ended December 31, 2024.Pre-provision, pre-tax net revenue  for the fourth quarter was $6.5 million, which represented a $706,000 (12%) increase over the third quarter of 2024. PPNR for the year ended December 31, 2024 was $22.9 million.Return on Average Equity  was 10.61% for the fourth quarter, while Return on Average Assets  was 0.86%.Net Interest Income for the fourth quarter of 2024 increased $1.0 million  when compared to the third quarter of 2024.Noninterest bearing  deposit balances increased by $38 million (16%) during 2024.Performance results for the fourth quarter of 2024 included PPNR of $6.5 million, which represented a 12% increase over the prior quarter. Also, du","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cf-bankshares-inc-parent-cfbank-140000142.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cf-bankshares-inc-parent-cfbank-140000142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NA","BK4195","BK4093","NIB","BK4024","ROE","NIM","BK4585","INC","BK4211","YEAR","FOR","BK4141","BK4588","CFBK","CF"],"gpt_icon":0},{"id":"2510866983","title":"Breakfast News: Activist Eyes Black Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866983","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510866983?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:08","pubTimestamp":1739275680,"startTime":"0","endTime":"0","summary":"Elliott targets the oil sector, Vertex builds pipeline, Upstart earnings due, and more...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/11/breakfast-news-activist-eyes-black-gold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["IVV","LU1093756325.SGD","BK4559","IE00BZ9MQY76.HKD","BK4567","LU2362541513.USD","BK4532","LU0234570918.USD","LU0256863811.USD","SSO","IE00B894F039.SGD","LU0079474960.USD",".SPX","BK4550","OEF","IE00B19Z3B42.SGD","BK4093","SH","CF","LU2236285917.USD","LU1035775433.USD","IE00B19Z3581.USD","LU1559883803.SGD","LU2324357040.USD","SDS","VERX","LU2362541273.HKD","VRTX","LU2362540622.SGD","BK4534","BK4023","OEX","IE00B4R5TH58.HKD","SPXU","UPRO","IE00B2B36J28.USD","IE0002270589.USD","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","VOO","LU1815336091.USD","LU0061475181.USD","BK4588","LU0058720904.USD","LU2237438978.USD","LU0757428866.USD","ESmain","SPY","LU0417517546.SGD"],"gpt_icon":0},{"id":"2510168278","title":"CF Industries Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2510168278","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510168278?lang=en_us&edition=fundamental","pubTime":"2025-02-11 06:16","pubTimestamp":1739225760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of CF Industries Holdings Inc.  rose 3.51% to $87.00 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.67% to 6,066.44 and the Dow Jones Industrial Average  rising 0.38% to 44,470.41.The stock's rise snapped a three-day losing streak.CF Industries Holdings Inc. closed 11.45% short of its 52-week high of $98.25, which the company reached on January 16th.The stock outperformed some of its competitors Monday, as Mosaic Co.  rose 2.16% to $27.43 and Westlake Corp.  fell 0.46% to $111.02.Trading volume  eclipsed its 50-day average volume of 1.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 10, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CF"],"gpt_icon":0},{"id":"2510890162","title":"Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890162","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890162?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:03","pubTimestamp":1739221380,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  10, 2025  (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023780/0/en/Sionna-Therapeutics-Announces-Closing-of-219-2-million-Upsized-Initial-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004091025.USD","LU2237443622.USD","BK4552","USA","LU2237443382.USD","CF","IE00B19Z3581.USD","IE0002270589.USD","BK4093","LU1791807156.HKD","LU0106831901.USD","LU2237443465.HKD","LU2237443895.HKD","IE0004086264.USD","IE00BSNM7G36.USD","IE0034235188.USD","SION","BK4516","BK4533","BK4585","BK4588","LU2237443549.SGD","BK4127","LU1668664300.SGD","IE00BFXG1179.USD","BK4504","BK4550","IE00B19Z3B42.SGD","LU2237443978.SGD","LU2237438978.USD"],"gpt_icon":0},{"id":"2510408700","title":"2 Biotech Stocks to Buy Hand Over Fist in February","url":"https://stock-news.laohu8.com/highlight/detail?id=2510408700","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510408700?lang=en_us&edition=fundamental","pubTime":"2025-02-09 23:15","pubTimestamp":1739114100,"startTime":"0","endTime":"0","summary":"Vertex has successfully diversified its already strong lineup of medicines.Moderna's drug pipeline should lead to more significant breakthroughs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/02/09/2-biotech-stocks-to-buy-hand-over-fist-in-february/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4533","LU1291159041.SGD","LU2089984988.USD","LU2468319806.SGD","IE00BN8TJ469.HKD","LU1934455194.USD","LU0211331839.USD","LU1061106388.HKD","LU0965508806.USD","LU0234570918.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU0256863811.USD","LU0266013472.USD","LU0823416689.USD","SG9999001176.USD","IE00BBT3K403.USD","LU1585245621.USD","SG9999002224.SGD","CF","VERX","LU0320765992.SGD","LU2023250843.SGD","MRK","BK4093","LU1035773651.USD","LU0320765646.SGD","IE00BJJMRZ35.SGD","LU0861579265.USD","IE00B1BXHZ80.USD","LU0889565916.HKD","VRTX","LU2361045086.USD","SG9999014542.SGD","LU0289739699.SGD","SCD","LU0965509101.SGD","LU2023250504.SGD","IE00B894F039.SGD","LU0985320562.USD","LU1069347547.HKD","LU1989772923.USD","IE00B4R5TH58.HKD","IE0002141913.USD","SG9999015358.SGD","LU1037948897.HKD","LU1929549753.HKD","LU2362541273.HKD","LU2461242641.AUD","LU0070302665.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.cfindustries.com","stockEarnings":[{"period":"1week","weight":-0.0187},{"period":"1month","weight":-0.1441},{"period":"3month","weight":-0.0527},{"period":"6month","weight":0.0186},{"period":"1year","weight":0.074},{"period":"ytd","weight":-0.0333}],"compareEarnings":[{"period":"1week","weight":0.0149},{"period":"1month","weight":0.0285},{"period":"3month","weight":0.0409},{"period":"6month","weight":0.0999},{"period":"1year","weight":0.2145},{"period":"ytd","weight":0.0403}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"CF Industries Holdings, Inc. manufactures and sells hydrogen and nitrogen products for energy, fertilizer, emissions abatement, and other industrial activities worldwide. Its principal products include anhydrous ammonia, granular urea, urea ammonium nitrate, and ammonium nitrate products. The company also offers diesel exhaust fluid, urea liquor, nitric acid, and aqua ammonia products; and compound fertilizer products with nitrogen, phosphorus, and potassium. It primarily serves cooperatives, independent fertilizer distributors, traders, wholesalers, and industrial users. The company was founded in 1946 and is headquartered in Deerfield, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.024238},{"month":2,"riseRate":0.7,"avgChangeRate":0.061428},{"month":3,"riseRate":0.263158,"avgChangeRate":-0.042154},{"month":4,"riseRate":0.631579,"avgChangeRate":0.018049},{"month":5,"riseRate":0.578947,"avgChangeRate":-0.047623},{"month":6,"riseRate":0.421053,"avgChangeRate":0.006911},{"month":7,"riseRate":0.842105,"avgChangeRate":0.063993},{"month":8,"riseRate":0.578947,"avgChangeRate":0.036127},{"month":9,"riseRate":0.65,"avgChangeRate":0.001582},{"month":10,"riseRate":0.45,"avgChangeRate":0.015258},{"month":11,"riseRate":0.65,"avgChangeRate":0.027108},{"month":12,"riseRate":0.7,"avgChangeRate":0.034502}],"exchange":"NYSE","name":"CF Industries Holdings Inc","nameEN":"CF Industries Holdings Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CF Industries Holdings Inc(CF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CF Industries Holdings Inc,CF,CF Industries Holdings Inc股票,CF Industries Holdings Inc股票老虎,CF Industries Holdings Inc股票老虎国际,CF Industries Holdings Inc行情,CF Industries Holdings Inc股票行情,CF Industries Holdings Inc股价,CF Industries Holdings Inc股市,CF Industries Holdings Inc股票价格,CF Industries Holdings Inc股票交易,CF Industries Holdings Inc股票购买,CF Industries Holdings Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CF Industries Holdings Inc(CF),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CF Industries Holdings Inc(CF) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction